KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Operating Expenses: 2009-2025

Historic Operating Expenses for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to $73.6 million.

  • Dynavax Technologies' Operating Expenses rose 4.33% to $73.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $320.1 million, marking a year-over-year increase of 17.77%. This contributed to the annual value of $281.4 million for FY2024, which is 4.48% up from last year.
  • Dynavax Technologies' Operating Expenses amounted to $73.6 million in Q3 2025, which was down 9.14% from $81.0 million recorded in Q2 2025.
  • Dynavax Technologies' Operating Expenses' 5-year high stood at $128.2 million during Q2 2022, with a 5-year trough of $43.6 million in Q2 2021.
  • Moreover, its 3-year median value for Operating Expenses was $70.5 million (2024), whereas its average is $72.5 million.
  • Per our database at Business Quant, Dynavax Technologies' Operating Expenses spiked by 263.66% in 2021 and then slumped by 50.36% in 2023.
  • Over the past 5 years, Dynavax Technologies' Operating Expenses (Quarterly) stood at $114.4 million in 2021, then rose by 6.12% to $121.4 million in 2022, then slumped by 47.19% to $64.1 million in 2023, then increased by 14.94% to $73.7 million in 2024, then grew by 4.33% to $73.6 million in 2025.
  • Its Operating Expenses stands at $73.6 million for Q3 2025, versus $81.0 million for Q2 2025 and $91.8 million for Q1 2025.